About
Aaron Nelson MD, PhD is a Managing Director at the Novartis Venture Fund in Cambridge, MA, USA. Prior to NVF, he was an investor at dRx Capital, a joint investment company of Novartis and Qualcomm, focused on Digital Medicine. Previously, Aaron worked on technology strategy across multiple Business Units within Novartis, including Strategic Project Leader for the Trials of the Future program and as Group Head in the Investigative Toxicology organization. Aaron studied Medicine at Tufts University, Cell and Microbiology at the University of Pennsylvania and the Karolinska Institutet, and completed his BSc at Cornell University.
